Designed to optimize bone regeneration, the new graft technology promises superior clinical outcomes in spinal and orthopedic procedures....
Unveiled at ESCMID Global Congress 2025, the new Hyperbaric Heating-based platform eliminates the need for extraction kits—delivering faster, simpler, and cost-effective molecular workflows across diverse research and diagnostic applications....
Utilizing advanced TMS technology, EXOMIND™ offers a drug-free, precision-based solution for mood regulation and cognitive enhancement in clinical and wellness settings....
New collaboration removes adoption barriers by offering streamlined evaluation of MoxiePlex systems through a CLIA-accredited lab, combining imaging expertise with validated spatial biology support. ...
Milestone Marks Completion of First-in-Human Study for Innovative OA Therapy ...
Innovative Solution Aims to Improve Recovery and Reduce Complications in Diabetes Care ...
Next-generation closed-loop DBS device now approved in Europe, offering real-time, personalized neuromodulation for Parkinson’s and other neurological disorders....
New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025....
With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players. ...
Strategic move strengthens Clario’s leadership in medical imaging and bolsters expertise in multiple sclerosis and neurological drug development....
